Rite Aid (RAD) Front-End Comps Rose 0.9% in June

Go back to Rite Aid (RAD) Front-End Comps Rose 0.9% in June

Goldman Sachs Comments on Rite-Aid (RAD) June Sales Data

July 3, 2014 10:38 AM EDT

Goldman Sachs maintained a Buy rating on Rite-Aid (NYSE: RAD) with a price target of $9.50. Comments follow June sales data. Analyst Robert P. Jones noted this was the strongest script comp since January 2013.

"RADs June SSS increased 3.9%, exceeding GS/consensus of 3.4%/2.8%, with script... More

Rite Aid (RAD), Walgreen (WAG) Gain on Strong June Sales Results

July 3, 2014 9:22 AM EDT

Retail pharmacy giants Walgreen (NYSE: WAG) and Rite Aid (NYSE: RAD) are positive Thursday following June sales results.

Walgreen reported... More